Your browser doesn't support javascript.
loading
MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab.
Mensà, E; Recchioni, R; Marcheselli, F; Giuliodori, K; Consales, V; Molinelli, E; Prattichizzo, F; Rippo, M R; Campanati, A; Procopio, A D; Olivieri, F; Offidani, A M.
Afiliación
  • Mensà E; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
  • Recchioni R; Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
  • Marcheselli F; Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
  • Giuliodori K; Dermatology Unit Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Consales V; Dermatology Unit Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Molinelli E; Dermatology Unit Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Prattichizzo F; Department of Cardiovascular Research, IRCCS MultiMedica, Milano, Italy.
  • Rippo MR; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
  • Campanati A; Dermatology Unit Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Procopio AD; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
  • Olivieri F; Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
  • Offidani AM; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
Br J Dermatol ; 179(3): 787-789, 2018 09.
Article en En | MEDLINE | ID: mdl-29624637

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Factor de Necrosis Tumoral alfa / MicroARNs / Adalimumab Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Factor de Necrosis Tumoral alfa / MicroARNs / Adalimumab Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido